Pricing Log in Create free account

Moolec Science SA (MLEC) vs Scinai Immunotherapeutics Ltd. Sponsored ADR (SCNI)

Moolec Science SA and Scinai Immunotherapeutics Ltd. Sponsored ADR are both Biotechnology companies. Moolec Science SA is the larger, with a market value of $620.0K against $320.0K — 1.9× the size. Moolec Science SA has negative trailing earnings, so its P/E is not meaningful; Scinai Immunotherapeutics Ltd. Sponsored ADR trades at 0.0×. Scinai Immunotherapeutics Ltd. Sponsored ADR has the higher net margin (0.00% vs −105.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Scinai Immunotherapeutics Ltd. Sponsored ADR leads on 6 and Moolec Science SA on 5.

Valuation

Metric MLEC SCNI Biotechnology median
P/E n/m 0.01 10.60
P/S 0.03 n/m 9.40
P/B 0.01 0.03 2.13
Price to free cash flow 0.01 n/m 25.18
EV/EBITDA 1.76 0.29 0.66
EV/Sales 8.37 n/m 9.02
Earnings yield (3,822.12%) 18,535.67% (32.88%)
Free cash flow yield 8,301.70% (3,801.33%) (23.13%)

Profitability

Metric MLEC SCNI Biotechnology median
Gross margin 2,373.25% 0.00% 68.51%
Operating margin 244.93% 0.00% 0.00%
Net margin (105.71%) 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% 0.00% (51.96%)
Return on assets 0.00% 0.00% (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric MLEC SCNI Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) (793.17%) (159.83%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MLEC SCNI Biotechnology median
Debt to equity 4.37 0.02 0.00
Current ratio 0.15 1.56 4.97
Net debt to EBITDA (2.73) 0.25 1.01

Dividend

Metric MLEC SCNI Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric MLEC SCNI Biotechnology median
Market cap 620.00k 320.00k 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack